Clinical Trial Update: Safety and Acceptability of Tenofovir 1% Gel in Adolescent Females [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the safety and acceptability of tenofovir 1% gel for HIV prevention in adolescent females has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• Tenofovir 1% Gel (tenofovir)

Snippet

Sponsor: CONRAD | Conditions: HIV Prevention | Phase 1 | Status: WITHDRAWN